Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17256989 | DYNAMIC MAKE-UP PRODUCT | December 2020 | April 2025 | Allow | 52 | 3 | 1 | Yes | No |
| 17133415 | SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN | December 2020 | March 2022 | Allow | 15 | 0 | 0 | No | No |
| 17126321 | DUAL PHASE PRODUCTS | December 2020 | November 2024 | Allow | 47 | 4 | 0 | Yes | No |
| 17127186 | Compressible Cannabinoid Pharmaceutical Composition | December 2020 | January 2022 | Abandon | 13 | 2 | 0 | No | No |
| 16972304 | COMPOSITION FOR INFLAMMATORY GASTROINTESTINAL DISORDERS | December 2020 | September 2022 | Allow | 21 | 2 | 0 | No | No |
| 15734147 | AQUEOUS FORMULATION COMPRISING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA | December 2020 | June 2024 | Allow | 42 | 2 | 0 | Yes | No |
| 17059790 | INJECTABLE THERMORESPONSIVE HYDROGELS AS A COMBINATORY MODALITY FOR CONTROLLED DRUG DELIVERY, BIOMATERIAL IMPLANT AND 3D PRINTING BIOINK | November 2020 | April 2025 | Allow | 52 | 6 | 0 | Yes | No |
| 17100677 | COMPOSITION AND THERAPY FOR TREATMENT OF GAG REFLEXES | November 2020 | July 2021 | Abandon | 8 | 1 | 0 | Yes | No |
| 16951335 | GEL COMPOSITIONS FOR MITIGATION OF BURN INJURIES, KITS CONTAINING THE GEL COMPOSITIONS, AND ASSOCIATED METHODS | November 2020 | December 2024 | Allow | 49 | 2 | 1 | No | No |
| 17053705 | Anti-Dandruff Composition | November 2020 | August 2023 | Allow | 33 | 3 | 1 | No | No |
| 17081827 | COSMETIC COMPOSITION FOR SKIN BARRIER STRENGTHENING OR MOISTURIZING COMPRISING FERMENTED RICE EXTRACTS, PINEAPPLE EXTRACTS, AND GLYCERYL GLUCOSIDE MIXTURE | October 2020 | May 2022 | Abandon | 19 | 1 | 0 | No | No |
| 17050470 | LIQUID ORAL PHARMACEUTICAL DOSAGE FORM | October 2020 | April 2022 | Allow | 18 | 1 | 0 | No | No |
| 17068683 | METHOD OF INCREASING DURABILITY OF OIL-IN-WATER EMULSION MAKEUP | October 2020 | November 2022 | Abandon | 25 | 2 | 0 | No | No |
| 17038928 | COSMETIC COMPOSITIONS COMPRISING 4-HYDROXYACETOPHENONE | September 2020 | June 2025 | Allow | 57 | 7 | 0 | Yes | No |
| 17039093 | DEO EMULSION FOR AEROSOLS, DEODORANT COMPRISING THE SAME AND USE OF THE DEODORANT | September 2020 | July 2022 | Allow | 21 | 2 | 0 | No | No |
| 17042555 | INTRAVAGINAL FORMULATION | September 2020 | August 2023 | Allow | 34 | 4 | 0 | No | No |
| 17031560 | DEO EMULSION FOR AEROSOLS WITH REDUCED STAIN PROBLEM, DEODORANT COMPRISING THE SAME AND USE OF THE DEODORANT | September 2020 | January 2022 | Allow | 16 | 1 | 0 | No | No |
| 16975543 | OXYGEN GENERATING FACE MASKS | August 2020 | November 2022 | Abandon | 27 | 2 | 0 | No | No |
| 16975302 | HARD-PRESSED SCORED SPLITTABLE MARIJUANA TABLETS | August 2020 | August 2024 | Abandon | 48 | 0 | 1 | No | No |
| 16971509 | COMPOSITIONS FOR PROVIDING SKIN CARE BENEFITS AND METHODS OF USE | August 2020 | October 2022 | Abandon | 26 | 1 | 0 | No | No |
| 16967940 | TREATMENT OF GRAM-NEGATIVE FOLLICULITIS OR AN INFLAMMATION THEREOF WITH BESIFLOXACIN | August 2020 | December 2022 | Abandon | 29 | 1 | 0 | No | No |
| 16915479 | VISIBLE LIGHT-CURABLE WATER-SOLUBLE CHITOSAN DERIVATIVE, CHITOSAN HYDROGEL, AND PREPARATION METHOD THEREFOR | June 2020 | August 2020 | Allow | 2 | 0 | 0 | Yes | No |
| 16913258 | METHOD FOR LYOPHILIZING EXOSOME | June 2020 | March 2022 | Allow | 21 | 1 | 0 | No | No |
| 16954833 | STORAGE STABLE MIXTURES | June 2020 | September 2024 | Allow | 51 | 2 | 0 | No | No |
| 16771519 | Antiperspirant / Deodorant Compositions Including Biodegradable Amino Carboxylates and Methods for the Same | June 2020 | October 2022 | Allow | 28 | 4 | 0 | No | No |
| 16891586 | COMPOSITIONS COMPRISING INDIGO AND/OR AN INDIGO DERIVATIVE AND METHODS OF USE THEREOF | June 2020 | July 2022 | Abandon | 25 | 0 | 1 | No | No |
| 16892213 | METHODS AND COMPOSITION FOR IMPROVED ANTISEPSIS | June 2020 | March 2022 | Abandon | 21 | 1 | 0 | No | No |
| 16884366 | Taurine and Aloe Synergistic Anti-Irritant Compositions and Methods | May 2020 | July 2021 | Allow | 14 | 3 | 0 | No | No |
| 16875683 | OIL-SOLUBLE DRUG CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF | May 2020 | October 2023 | Abandon | 41 | 3 | 1 | No | No |
| 16874300 | CANNABIDIOL NANOCRYSTAL COMPOSITIONS | May 2020 | June 2023 | Abandon | 37 | 4 | 0 | No | No |
| 16762943 | ORGANOSILICON ANTIMICROBIAL SOLUTION, ORGANOSILICON ANTIMICROBIAL AGENT, ANTIMICROBIAL GLASS, PREPARATION METHOD THEREFOR AND USE THEREOF | May 2020 | October 2021 | Allow | 17 | 2 | 0 | No | No |
| 16762860 | HYDROGEL DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF PEDIATRIC GROWTH PLATE INJURIES | May 2020 | April 2024 | Abandon | 47 | 3 | 1 | No | No |
| 16762138 | A THERMO-RESPONSIVE HYDROGEL FOR INTRATUMORAL ADMINISTRATION AS A TREATMENT IN SOLID TUMOR CANCERS | May 2020 | August 2022 | Allow | 27 | 3 | 0 | No | No |
| 16761357 | EMULSION COMPRISING AN ANIONIC ACRYLIC COPOLYMER AND A LIPOPHILIC POLYMER | May 2020 | August 2022 | Allow | 27 | 2 | 0 | No | No |
| 16865183 | COMPOSITIONS COMPRISING INDIGO AND/OR AN INDIGO DERIVATIVE AND METHODS OF USE THEREOF | May 2020 | June 2022 | Abandon | 26 | 1 | 1 | No | No |
| 16760191 | COSMETIC EMULSION CONTAINING A GEMINI SURFACTANT AND A LIPOPHILIC POLYMER | April 2020 | January 2025 | Allow | 57 | 6 | 0 | Yes | No |
| 16759925 | METHOD FOR THE FORMULATION OF OIL-SOLUBLE SUBSTANCES, AND POWDERS OBTAINABLE THEREOF | April 2020 | December 2023 | Allow | 43 | 3 | 0 | No | No |
| 16758434 | Personal Care Compositions Including Naringin:zinc Complexes and Methods for the Same | April 2020 | June 2021 | Allow | 13 | 1 | 0 | No | No |
| 16755818 | LIQUID COSMETIC WITH AGAR SHELL CAPSULE | April 2020 | June 2022 | Allow | 26 | 2 | 1 | No | No |
| 16753726 | RAPID ONSET AND EXTENDED ACTION PLANT-BASED AND SYNTHETIC CANNABINOID FORMULATIONS | April 2020 | April 2022 | Abandon | 25 | 0 | 1 | No | No |
| 16651403 | DELIVERY SYSTEMS FOR PEROXIDE COMPOUNDS AND THEIR APPLICATIONS | March 2020 | March 2023 | Allow | 36 | 4 | 0 | No | No |
| 16804856 | HIGH POLYOL WASH COMPOSITION | February 2020 | November 2021 | Abandon | 20 | 1 | 0 | No | No |
| 16788563 | THERAPEUTIC COMPOSITION AND METHODS | February 2020 | September 2022 | Allow | 32 | 2 | 1 | No | Yes |
| 16777949 | CELLULOSE COMPOSITION | January 2020 | March 2024 | Allow | 50 | 4 | 0 | Yes | No |
| 16635068 | COSMETIC | January 2020 | May 2022 | Allow | 27 | 2 | 0 | Yes | No |
| 16775253 | PHOSPHOLIPID COMPOUNDS AND FORMULATIONS | January 2020 | October 2020 | Allow | 9 | 1 | 0 | Yes | No |
| 16744497 | METHODS OF MAKING POLYTETRAFLUOROETHYLENE/POLYMER COMPOSITES AND USES THEREOF | January 2020 | August 2024 | Allow | 55 | 4 | 1 | No | No |
| 16631208 | Efficacy of a Gastro-Retentive Bile Acid Sequestrant Dosage Form | January 2020 | December 2023 | Abandon | 47 | 0 | 1 | No | No |
| 16742675 | System, Method and Compositions for Treating Age-Related Illnesses and Conditions | January 2020 | March 2023 | Abandon | 38 | 1 | 0 | No | No |
| 16629639 | SUNSCREEN AGENT WITH A PROTECTION AGAINST TEXTILE SPOTTING DUE TO 4-(TERT.-BUTYL)-4'-METHOXYDIBENZOYLMETHANE | January 2020 | December 2021 | Abandon | 23 | 1 | 0 | No | No |
| 16720223 | PH-Sensitive Starch-Based Microcapsule and Its Preparation Method | December 2019 | June 2021 | Allow | 18 | 1 | 0 | No | No |
| 16623834 | TOPICAL COMPOSITIONS AND METHODS OF USING THE SAME | December 2019 | October 2021 | Abandon | 22 | 2 | 0 | No | No |
| 16715223 | TWO-COMPONENT HAIR CARE AGENT WITH COLOR INDICATOR FOR THE IDENTIFICATION OF THE OPTIMUM PH VALUE, METHOD OF APPLYING THE SAME AND USING THE SAME | December 2019 | December 2022 | Abandon | 36 | 4 | 0 | Yes | No |
| 16622742 | NASAL COMPOSITION | December 2019 | November 2021 | Abandon | 23 | 1 | 0 | No | No |
| 16708326 | PROCESS FOR INFUSING A TERPENE SOLUTION INTO A STORAGE CONTAINER THAT STORES CANNABIS | December 2019 | February 2023 | Abandon | 38 | 1 | 0 | No | No |
| 16615434 | LIQUID CLEANSING COMPOSITION | November 2019 | January 2021 | Allow | 14 | 1 | 0 | No | No |
| 16614330 | SUNSCREEN COMPOSITION | November 2019 | April 2025 | Allow | 60 | 8 | 0 | Yes | No |
| 16685330 | HAIR OILS FOR CONDITIONING KERATIN FIBRES | November 2019 | November 2021 | Allow | 24 | 4 | 0 | No | No |
| 16684073 | COMBINATION TREATMENT OF BACTERIAL INFECTION | November 2019 | February 2023 | Allow | 39 | 4 | 0 | No | No |
| 16670163 | METHODS OF TREATMENT USING NIMODIPINE PARENTERAL FORMULATIONS | October 2019 | December 2020 | Abandon | 13 | 1 | 0 | No | No |
| 16669233 | COMPOSITION COMPRISING 2-ETHYL-1,3-HEXANEDIOL FOR USE IN A DEODORANT SPRAY OR ANTIPERSPIRANT SPRAY | October 2019 | February 2022 | Abandon | 27 | 3 | 0 | No | No |
| 16668580 | COLOR- AND CLARITY-STABLE NATURAL MICELLAR WATER | October 2019 | February 2025 | Allow | 60 | 8 | 0 | Yes | No |
| 16609346 | Cosmetic Compositions for Skin Health and Methods of Using Same | October 2019 | May 2022 | Allow | 31 | 3 | 0 | No | No |
| 16665344 | Solid Bar Shampoo | October 2019 | August 2021 | Abandon | 22 | 2 | 0 | Yes | No |
| 16606804 | LOW VISCOSITY, HIGH POLYOL SELF-FOAMING COMPOSITION | October 2019 | April 2025 | Allow | 60 | 4 | 0 | No | Yes |
| 16606936 | IODINE COMPOSITIONS | October 2019 | November 2021 | Allow | 24 | 2 | 0 | No | No |
| 16656180 | GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR | October 2019 | July 2023 | Abandon | 45 | 2 | 1 | No | No |
| 16604473 | PERSONAL CARE PRODUCTS | October 2019 | October 2022 | Allow | 37 | 2 | 0 | Yes | No |
| 16604019 | METHOD FOR REMOVING KERATOTIC PLUGS | October 2019 | April 2022 | Allow | 30 | 2 | 0 | Yes | No |
| 16500932 | NANOFIBERS COMPRISING FIBROIN AS WELL AS SYSTEM COMPRISING HYDROGEL AND SAID NANOFIBERS | October 2019 | March 2023 | Abandon | 41 | 1 | 1 | No | No |
| 16498943 | Pharmaceutical formulation | September 2019 | September 2022 | Allow | 36 | 2 | 0 | Yes | No |
| 16578040 | Gel Texturizer Base for Cosmetics | September 2019 | May 2022 | Abandon | 32 | 1 | 1 | No | No |
| 16492903 | COMPLEXES FOR TREATING SENSITIVITY | September 2019 | January 2025 | Allow | 60 | 4 | 1 | No | No |
| 16560084 | Eye Drops for Treatment of Irritation Not Due to Infection | September 2019 | February 2021 | Allow | 17 | 1 | 0 | No | No |
| 16491030 | PHARMACEUTICAL FORMULATIONS OF PHLOROGLUCINOL AND TRIMETHYLPHLOROGLUCINOL | September 2019 | October 2023 | Abandon | 49 | 4 | 1 | No | No |
| 16554134 | OPHTHALMIC FORMULATIONS, PROCESS FOR PREPARING THE SAME AND METHOD FOR ADMINISTERING THE SAME | August 2019 | January 2022 | Abandon | 29 | 3 | 0 | No | No |
| 16485934 | WATER-SOLUBLE NANOCERIA AND METHODS OF MAKING AND USING THE SAME | August 2019 | October 2021 | Abandon | 27 | 3 | 0 | Yes | No |
| 16537823 | THERAPEUTIC COMPOSITION AND METHODS | August 2019 | September 2022 | Allow | 38 | 2 | 1 | Yes | Yes |
| 16484430 | TOPICAL FORMULATIONS AND METHODS | August 2019 | April 2023 | Allow | 45 | 4 | 0 | Yes | No |
| 16484408 | A HAIR CONDITIONING COMPOSITION | August 2019 | April 2022 | Abandon | 32 | 4 | 0 | Yes | No |
| 16481613 | ADMINISTRATION REGIMEN FOR A PHARMACEUTICAL PATCH COMPRISING LIDOCAINE AND DICLOFENAC | July 2019 | June 2023 | Abandon | 46 | 5 | 0 | Yes | No |
| 16525120 | Photoresist and Method | July 2019 | October 2019 | Allow | 3 | 1 | 0 | No | No |
| 16517423 | RESPIRATORY TRACT DELIVERY OF LEVODOPA AND DOPA DECARBOXYLASE INHIBITOR FOR TREATMENT OF PARKINSON'S DISEASE | July 2019 | July 2022 | Allow | 36 | 5 | 0 | Yes | No |
| 16478883 | Biochloride Generation and Methods | July 2019 | September 2021 | Abandon | 26 | 2 | 0 | No | No |
| 16476633 | MICROCAPSULES COMPRISING CINMETHYLN IN THE CORE AND A POLYUREA DERIVED FROM DIPHENYLMETHANE DIISOCYANATE OR AN OLIGOMER THEREOF | July 2019 | April 2025 | Allow | 60 | 7 | 1 | No | No |
| 16475283 | METHODS OF REMOVING SPORES | July 2019 | January 2025 | Abandon | 60 | 8 | 0 | No | No |
| 16474096 | WATER-IN-OIL EMULSION COSMETIC | June 2019 | October 2022 | Allow | 40 | 5 | 0 | No | No |
| 16474393 | PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURING THE SAME | June 2019 | September 2021 | Allow | 27 | 4 | 0 | Yes | No |
| 16474083 | METHODS AND DEVICES FOR TREATING LEVODOPA INDUCED DYSKINESIA | June 2019 | May 2021 | Abandon | 23 | 0 | 1 | No | No |
| 16453813 | COMPOSITION COMPRISING A CROSSLINKED HYALURONIC ACID (HA) IN COMBINATION WITH A LOW-MOLECULAR HA AND/OR AN AGENT STIMULATING ENDOGENOUS HA SYNTHESIS | June 2019 | September 2021 | Allow | 27 | 3 | 0 | Yes | No |
| 16473693 | Substituted Heterocycle Fused Gamma-Carbolines for Treatment of Central Nervous System Disorders | June 2019 | November 2020 | Allow | 17 | 1 | 0 | Yes | No |
| 16453798 | MICRO- OR NANOPARTICULAR MULTILAMELLAR VESICLES, COMPOSITIONS COMPRISING THE SAME AND METHOD FOR THEIR USE IN SKIN CARE | June 2019 | July 2021 | Abandon | 25 | 2 | 0 | No | No |
| 16453230 | METHODS OF PROMOTING THE HEALING OF CONCAVE WOUNDS | June 2019 | March 2022 | Abandon | 33 | 3 | 1 | No | No |
| 16446634 | ORAL pH INDEPENDENT DOSAGE FORMULATION FOR TREATING NEURODEGENERATIVE DISORDERS | June 2019 | November 2020 | Allow | 17 | 1 | 1 | No | No |
| 16470873 | METHOD FOR PRODUCING BEADS | June 2019 | March 2023 | Abandon | 45 | 4 | 0 | No | No |
| 16470513 | PERSONAL CARE COMPOSITIONS WITH CYSTINE | June 2019 | November 2021 | Allow | 29 | 3 | 0 | No | Yes |
| 16469863 | THERAPEUTIC AGENT FOR ONYCHOMYCOSIS | June 2019 | October 2020 | Abandon | 16 | 1 | 0 | No | No |
| 16469763 | OIL-IN-WATER TYPE COMPOSITION | June 2019 | June 2022 | Abandon | 36 | 4 | 0 | No | No |
| 16427274 | SKIN LIGHTENING COMPOSITIONS AND METHODS | May 2019 | September 2020 | Allow | 16 | 2 | 0 | Yes | No |
| 16464643 | Ultrastable Gold Nanoparticles For Drug Delivery Applications And Synthesis Thereof | May 2019 | October 2023 | Abandon | 53 | 5 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner LEE, SIN J.
With a 50.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 18.2% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner LEE, SIN J works in Art Unit 1613 and has examined 261 patent applications in our dataset. With an allowance rate of 65.9%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 30 months.
Examiner LEE, SIN J's allowance rate of 65.9% places them in the 28% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by LEE, SIN J receive 2.60 office actions before reaching final disposition. This places the examiner in the 72% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by LEE, SIN J is 30 months. This places the examiner in the 58% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.
Conducting an examiner interview provides a +27.9% benefit to allowance rate for applications examined by LEE, SIN J. This interview benefit is in the 74% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 19.1% of applications are subsequently allowed. This success rate is in the 22% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 44.1% of cases where such amendments are filed. This entry rate is in the 68% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 0% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 80.0% of appeals filed. This is in the 71% percentile among all examiners. Of these withdrawals, 75.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 73.2% are granted (fully or in part). This grant rate is in the 78% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 1.1% of allowed cases (in the 68% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 0% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.